- Peak Annual Net Revenue Potential for SUBLOCADE® Increased to >$1.5 Billion
- Attractive and Scalable Business Outlined – Expects Strong Net Revenue Growth and Operating Margin Expansion Over the Medium-term
Read more at prnewswire.comAll information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
- Peak Annual Net Revenue Potential for SUBLOCADE® Increased to >$1.5 Billion
- Attractive and Scalable Business Outlined – Expects Strong Net Revenue Growth and Operating Margin Expansion Over the Medium-term
Read more at prnewswire.com| Symbol | Last | Chg | %Chg |
|---|---|---|---|
| OPNT | 20.65 | -0.12 | -0.58% |
| Opiant Pharmaceuticals Inc | |||